Publicaciones en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (17)

2023

  1. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study

    The Lancet Neurology, Vol. 22, Núm. 12, pp. 1150-1159

2021

  1. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project

    Brain Sciences, Vol. 11, Núm. 8

2020

  1. Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)

    Psychopharmacology

  2. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats

    Psychopharmacology, Vol. 237, Núm. 8, pp. 2419-2431

2019

  1. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease

    Neurobiology of Aging, Vol. 75, pp. 126-135

2015

  1. Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches

    Neuroscience and Biobehavioral Reviews, Vol. 56, pp. 294-314

  2. From unilateral to bilateral parkinsonism: Effects of lateralization on dyskinesias and associated molecular mechanisms

    Neuropharmacology, Vol. 97, pp. 365-375

2014

  1. Sustained Increase of PKA Activity in the Postcommissural Putamen of Dyskinetic Monkeys

    Molecular Neurobiology, Vol. 50, Núm. 3, pp. 1131-1141

2013

  1. Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)

    Neurologia, Vol. 28, Núm. 8, pp. 503-521

  2. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease

    Experimental Neurology, Vol. 250, pp. 304-312

  3. l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata

    Synapse, Vol. 67, Núm. 7, pp. 407-414

2011

  1. Continuous dopaminergic stimulation: Clinical aspects and experimental bases

    Neurologist, Vol. 17, Núm. 6 SUPPL.

2009

  1. Fractal dimension analysis of grey matter in multiple sclerosis

    Journal of the Neurological Sciences, Vol. 282, Núm. 1-2, pp. 67-71

  2. Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats

    Psychopharmacology, Vol. 204, Núm. 2, pp. 241-250

2008

  1. Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes

    Neurobiology of Disease, Vol. 32, Núm. 3, pp. 340-348

  2. Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease

    Movement Disorders, Vol. 23, Núm. SUPPL. 3

2006

  1. Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: Have we wasted our time?

    Experimental Neurology